About Simon Tate, Ph.D.
Form D filings for CuraSen Therapeutics in 2024 list Simon Tate, Ph.D. as director.
Simon Tate, Ph.D. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Simon Tate, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Simon Tate, Ph.D. works with at each company, as listed on that company's latest Form D.
CuraSen Therapeutics, Inc. · Form D, Sep 18, 2024
RH
Ron Hunt
Director
AF
Anthony Ford
President and Chief Executive Officer, director
BP
Benjamin Potter
Executive officer
LD
Loretta Tse, Ph.D.
Director
KG
Kathleen Glaub
Director
PE
Patrick Enright
Director